Product Images Bromsite 0.075%

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 10 images provide visual information about the product associated with Bromsite 0.075% NDC 49708-754 by Sun Pharmaceutical Industries, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Bromfenac Chemical Structure - bromsite 01

Bromfenac Chemical Structure - bromsite 01

Instructions for Use - Figure A - bromsite 02

Instructions for Use - Figure A - bromsite 02

Instructions for Use - Figure B - bromsite 03

Instructions for Use - Figure B - bromsite 03

Instructions for Use - Figure C - bromsite 04

Instructions for Use - Figure C - bromsite 04

Instructions for Use - Figure D - bromsite 05

Instructions for Use - Figure D - bromsite 05

Instructions for Use - Figure E - bromsite 06

Instructions for Use - Figure E - bromsite 06

Instructions for Use - Figure F - bromsite 07

Instructions for Use - Figure F - bromsite 07

5 mL Foil Wrapper - bromsite 08

5 mL Foil Wrapper - bromsite 08

5 mL Bottle Label - bromsite 09

5 mL Bottle Label - bromsite 09

This is a description of an ophthalmic solution with the active ingredient bromenacsdum. It is free of obraenac and comes in a bottle with the NDC code 49708-754-41. The lot number is AB12C34D and the expiration date is 01/10. There is additional text that is not readable.*

5 mL Carton Label - bromsite 10

5 mL Carton Label - bromsite 10

This is a description for a pharmaceutical product. It is an ophthalmic solution named "BromSITE" containing an active ingredient called "bromfenac sodium sesquihydrate" and other inactive ingredients such as "Sodium Citrate Poloxamer 407", "Pobcarbophi", "Sodium Chloride", and "Edetate Disodium". This product is intended for topical application into the eye and distributed by Sun Pharmaceutical Industries Inc. at Cranbury, NJ 08512. The recommended dosage is one drop into the affected eye twice per day beginning one day prior to the surgery. It comes in a sterile 5 mL container with a protective seal that should be discarded after treatment completion. The product should be kept in the original unopened container at 15°C-25°C, and it is for Rx only. The prescribing information is enclosed with the product.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.